lanadelumab (takhzyro) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Fast Track FDA
AACT Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$16557.6600

VA FSS

$21551.5200

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
lanadelumab 300 mg / 2 mL (2 mL INJECTION) $16557.6600 VA Big4
  • TAKHZYRO (1)
    		•  Takeda Pharmaceuticals America, Inc.
    lanadelumab 300 mg / 2 mL (2 mL INJECTION) $21551.5200 VA FSS
  • TAKHZYRO (1)
    		•  Takeda Pharmaceuticals America, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue